OmniTier says its new tech platform has big implications for the spread of personalized medicine.
Author’s archive
The fund has invested $500K so far; Ambient Clinical Analytics is the latest recipient.
The platform allows health researchers to bring zebrafish embryos to life after freezing.
A new 13-member research team will analyze the relationship between gut bacteria and colon cancer.
The vision sees ‘BRT’ circulator connecting Mayo Clinic with 6,000 new parking spaces.
Proceeds from the Rochester loan will be used to expand operations, create jobs and develop a new product, identified as “on field-mixed reality training.”
The National Science Foundation sees commercialization potential in the University of Minnesota’s “synthetic incompatibility” process that can target certain mosquito populations.
The University of Minnesota’s Office for Technology Commercialization is offering the algorithm for licensing opportunities.
Three proposals would build or renovate 529 guest rooms around Mayo Clinic.
Miromatrix, Superior Organoid, and MNPHARM each landed $100,000 regenerative medicine awards.
A collaboration between Mayo and Exact Sciences is yielding accurate blood DNA tests for treatable cases.
The deal will seek to commercialize the Preparing Heart and Mind educational app for parents of babies with heart defects.
Noaber Foundation led a $1.5 million venture round for the digital health platform.
Magenta Therapeutics looks to expand the amount of stem cells for marrow transplants.
The new printer has been proven capable of printing out skin cells to repair wounds in tests on mice.
Cytox Ltd. will use bio-samples from Mayo to develop an algorithm predicting genetic vulnerability.
Partnering company MRI Interventions says the next step will be filing a 510(k), which will come in the third quarter.
The institute will focus on treatments for “cellular senescence” to slow the aging process.